Octapharma Fact Sheet 2012

Fact Sheet 2012

Annual Report 2011

Annual_Report_2011.pdf

Annual Report 2010

Annual_Report_2010.pdf

Mission & Vision

Our Group-wide mission is the safe and optimal use of human proteins.

 

Octapharma respects donated human plasma as a scarce and valuable resource. We meet our Mission through the use of cutting-edge, validated viral inactivation and state-of-the-art purification technologies, in order to achieve the highest production yields and manufacture medical products with the highest possible safety margins. We respect human plasma as a sparce resource for life saving therapies.

Octapharma has implemented a strategy of continuous investment in, and enhancement of, existing products as well as ongoing projects to develop a world-class portfolio of human proteins for the future.

In addition to our plasma-based activities, Octapharma has dedicated increasing resources over the past decade to recombinant protein research and development. This involves the use of cultured human cells to produce therapeutic protein products.

Our vision is to continuously improve treatment for the benefit of all patients with life-threatening diseases, by engaging top researchers in R&D regularly contributing new clinical information, and establishing solid relationships with patient-centered organisations.